These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25646356)
1. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer. Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
3. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers. Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015 [TBL] [Abstract][Full Text] [Related]
4. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer. Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174 [TBL] [Abstract][Full Text] [Related]
5. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer. Liu K; Chen HL; Gu MM; You QS Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Machado-Rugolo J; Fabro AT; Ascheri D; Farhat C; Ab'Saber AM; de Sá VK; Nagai MA; Takagaki T; Terra R; Parra ER; Capelozzi VL Hum Pathol; 2019 Jan; 83():177-191. PubMed ID: 30218756 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010 [TBL] [Abstract][Full Text] [Related]
8. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases. Søes S; Sørensen BS; Alsner J; Overgaard J; Hager H; Hansen LL; Kristensen LS Lung Cancer; 2013 Aug; 81(2):180-6. PubMed ID: 23643276 [TBL] [Abstract][Full Text] [Related]
9. Predicting the sites of metastases from lung cancer using molecular biologic markers. D'Amico TA; Aloia TA; Moore MB; Conlon DH; Herndon JE; Kinch MS; Harpole DH Ann Thorac Surg; 2001 Oct; 72(4):1144-8. PubMed ID: 11603427 [TBL] [Abstract][Full Text] [Related]
10. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer. Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma]. Ucvet A; Kul C; Gursoy S; Erbaycu AE; Kaya SO; Dinc ZA; Yucel N Arch Bronconeumol; 2011 Aug; 47(8):397-402. PubMed ID: 21696876 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal study on circulating miRNAs in patients after lung cancer resection. Leidinger P; Galata V; Backes C; Stähler C; Rheinheimer S; Huwer H; Meese E; Keller A Oncotarget; 2015 Jun; 6(18):16674-85. PubMed ID: 26078336 [TBL] [Abstract][Full Text] [Related]
14. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer. Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322 [TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
18. Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value. Chen L; Hu X; Wu H; Jia Y; Liu J; Mu X; Wu H; Zhao Y Pathol Res Pract; 2019 Mar; 215(3):427-432. PubMed ID: 30455129 [TBL] [Abstract][Full Text] [Related]
19. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer. Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]